Delivery Order SPE2DB25D3005-SPE2DB25FQJSP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $8,602.31 on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,890.11 on June 16, 2025, for the supply of Orencia 125 mg/ml syringes. This firm fixed-price delivery order, which is due for completion on June 17, 2025, was competitively awarded without set-aside designation to support the Medical Supply Chain, a division of the Defense Logistics Agency under the Department of Defense. The award represents a child contract under...
- The Defense Logistics Agency awarded a $11,893.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Orencia 125 mg/ml syringes. This non-set-aside competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $20,773.97 on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Orencia 125 mg/ml syringes valued at $14,495.04. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $49,728.04 to AmerisourceBergen Drug Corp for the supply of Orencia 125 mg/mL syringes. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of May 19, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,316.24 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, a biologic medication used primarily for rheumatoid arthritis treatment. The contract was awarded on May 8, 2025, with an ultimate completion date of May 9, 2025, and utilizes firm fixed pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $7,141.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes on September 29, 2025, with completion scheduled for September 30, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,570.63 on July 14, 2025, for the supply of Orencia 125 mg/ml syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $3,964.23 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Orencia 125 mg/ml syringes. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract contains no set-aside designation and is set to conclude on August 7,...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQJSPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $9,176.76 on September 15, 2025, with completion scheduled for September 16, 2025. This non-competitive delivery order uses firm fixed pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with the DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Orencia is a biologic immunosuppressant medication primarily used to treat rheumatoid arthritis and other autoimmune conditions, supporting the Department of Defense's medical supply needs for military personnel and beneficiaries. This delivery order is executed under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor to federal healthcare systems, AmerisourceBergen supplies an extensive range of medications and medical supplies to support military healthcare programs globally. The IDC vehicle enables the company to fulfill ongoing pharmaceutical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through flexible ordering mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 9/15/25 |